Accordingly, selective inhibitors of NaV1.7 and NaV1.8, and to a lesser extent NaV1.6 which is also found in motor nerves, may be promising therapeutics for management of the symptomatology of ciguatera in the clinic. This evidence concerns the gene SCN9A and ciguatera fish poisoning.